Comprehensive post Pete,
I agree the big unknown is when will Big Pharma (or Mid Cap/Big Cap Pharma) move.
Ely Lilly and Elanco have all that data and know it well, maybe that’s what MT means when he says Mid Cap/Big Cap. They share the drug for human and animal use.
Either way, we may have the bidding war MT was looking for as early as when the preclinical results come out for AD, PD, HD, FTD.
Maybe they did the capital raise to twelve million dollars for other reasons.
Havenots
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-639
-
- There are more pages in this discussion • 181 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $91.22M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 21.5¢ | 20.5¢ | $174.5K | 841.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 458470 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 144453 | 3 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |